🇺🇸 Gemzar in United States

7,764 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 7,764

Most-reported reactions

1. Death — 1,276 reports (16.43%)
2. Malignant Neoplasm Progression — 1,043 reports (13.43%)
3. Off Label Use — 1,001 reports (12.89%)
4. Nausea — 735 reports (9.47%)
5. Fatigue — 664 reports (8.55%)
6. Pyrexia — 660 reports (8.5%)
7. Dyspnoea — 650 reports (8.37%)
8. Anaemia — 610 reports (7.86%)
9. Thrombocytopenia — 584 reports (7.52%)
10. Vomiting — 541 reports (6.97%)

Source database →

Frequently asked questions

Is Gemzar approved in United States?

Gemzar does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Gemzar in United States?

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.